Paper339075
Mutagenicity of hydroxamic acids for Salmonella typhimurium.
Wang CY. Mutat Res, 1977. Cited by 31 papers, by iCite.
Cite this record
ConductScience Library. Mutagenicity of hydroxamic acids for Salmonella typhimurium. Papers, record 339075. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/339075
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics5
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Hydroxamic Acids | Major topic |
| Mutagens | Major topic |
| Genetic Techniques | |
| Histidine | |
| Salmonella typhimurium |
Source PubMed
Cited by10
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 31 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42614841 | Exploration of non-hydroxamate based quinoline analogues as HDAC8 inhibitors. | RSC Adv | 2026 | https://conductscience.org/library/papers/42614841 | PubMed |
| 39610753 | Slow-Binding and Covalent HDAC Inhibition: A New Paradigm? | JACS Au | 2024 | https://conductscience.org/library/papers/39610753 | PubMed |
| 38782078 | Replacement of the hydroxamic acid group in the selective HDAC8 inhibitor PCI-34051. | Bioorg Med Chem Lett | 2024 | https://conductscience.org/library/papers/38782078 | PubMed |
| 38472276 | Inhibition of urease-mediated ammonia production by 2-octynohydroxamic acid in hepatic encephalopathy. | Nat Commun | 2024 | https://conductscience.org/library/papers/38472276 | PubMed |
| 36694011 | Cytotoxic evaluation of YSL-109 in a triple negative breast cancer cell line and toxicological evaluations. | Naunyn Schmiedebergs Arch Pharmacol | 2023 | https://conductscience.org/library/papers/36694011 | PubMed |
| 34500583 | Non-Hydroxamate Zinc-Binding Groups as Warheads for Histone Deacetylases. | Molecules | 2021 | https://conductscience.org/library/papers/34500583 | PubMed |
| 31865813 | A patent review of histone deacetylase 6 inhibitors in neurodegenerative diseases (2014-2019). | Expert Opin Ther Pat | 2020 | https://conductscience.org/library/papers/31865813 | PubMed |
| 26603496 | Why Hydroxamates May Not Be the Best Histone Deacetylase Inhibitors--What Some May Have Forgotten or Would Rather Forget? | ChemMedChem | 2016 | https://conductscience.org/library/papers/26603496 | PubMed |
| 20386668 | Mutagenicity of new lead compounds to treat sickle cell disease symptoms in a Salmonella/microsome assay. | Int J Mol Sci | 2010 | https://conductscience.org/library/papers/20386668 | PubMed |
| 3771124 | S.E.M. study of urease-induced crystalluria in the presence of hydroxamic derivatives. | Int Urol Nephrol | 1986 | https://conductscience.org/library/papers/3771124 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/339075
GET https://conductscience.org/api/papers/v1/339075/authors